The success of Mycobacterium tuberculosis (Mtb) as a human pathogen relies on its ability to resist eradication by the immune system. The identification of mechanisms that enable Mtb to persist is key for finding ways to limit latent tuberculosis, which affects one-third of the world's population. Here we show that conditional gene silencing can be used to determine whether an Mtb gene required for optimal growth in vitro is also important for virulence and, if so, during which phase of an infection it is required. Application of this approach to the prcBA genes, which encode the core of the mycobacterial proteasome, revealed an unpredicted requirement of the core proteasome for the persistence of Mtb during the chronic phase of infection in mice. Proteasome depletion also attenuated Mtb in interferonc-deficient mice, pointing to a function of the proteasome beyond defense against the adaptive immune response. Genes that are essential for growth in vitro, in vivo or both account for approximately 20% of Mtb's genome. Conditional gene silencing could therefore facilitate the validation of up to 800 potential Mtb drug targets and improve our understanding of host-pathogen dynamics.
Many life-threatening infections are due to pathogens that commonly establish long-lasting latent infections before causing clinical disease. Approximately 1.8 billion people are estimated to be latently infected with one such pathogen, Mycobacterium tuberculosis, and at least 5% of these infected individuals will eventually develop tuberculosis and require chemotherapy 1 . Mtb survives in an infected host despite having induced strong cell-mediated immunity. In mice, persistence of Mtb is observed as prolonged survival in lungs at nearly constant bacterial titers, resulting in a chronic infection 2 . Using Mtb mutants that are attenuated during chronic infections in experimental animals can help to identify pathways to target for the eradication of persistent bacteria. Unfortunately, relatively little is known about the genetic repertoire that Mtb requires to avoid clearance by the immune system and persist in its host. So far, deletion or transposon mutatgenesis has been used to identify some genes that contribute to persistenceincluding those involved in intermediary metabolism, cell envelope modification or heat shock control genes 2 . However, this approach can neither determine which of the many genes that are essential for growth in vitro 3 are required in vivo, nor identify which of the genes that are essential for growth in vivo 4 are also required for persistence (because if a gene is essential for in vitro or in vivo growth, the mutant does not grow to a titer that would allow for the identification of a persistence phenotype in mice).
To faciliate the analysis of genes that are essential for Mtb growth, we previously generated regulated mycobacterial expression systems that are controlled by tetracycline repressors (TetRs) [5] [6] [7] . These expression systems have allowed for the construction of conditional knockdown mutants of Mycobacterium smegmatis and Mycobacterium bovis BCG, in which expression of a single target gene can be silenced either by addition (Tet-OFF system) or by removal of tetracycline (Tet-ON system) 5, 7, 8 . For this study, we aimed to determine whether Tet-ON and Tet-OFF systems can also be used to generate conditional knockdown mutants in virulent Mtb and whether Mtb genes can be silenced during mouse infections. We selected the mycobacterial 20S proteasome as the target for gene silencing.
The Mtb 20S proteasome core consists of 14 a subunits encoded by prcA and 14 b subunits encoded by prcB, which assemble into an a 7 b 7 b 7 a 7 complex 9,10 . Bacterial proteasomes, which are unique to actinomycetes 11 , are not essential for in vitro growth of Streptomyces coelicolor, Streptomyces lividans, or M. smegmatis [12] [13] [14] . In contrast, prcA and prcB were predicted to be essential for optimal in vitro growth of Mtb 3 . Inactivation of two proteasome-associated genes, mpa and pafA, reduced Mtb virulence in mice, suggesting that the proteasome is also important for pathogenicity 15, 16 . Mpa encodes a proteasomal ATPase, which is homologous to ATPases found in the regulatory cap of the eukaryotic 26S proteasome and is likely involved in substrate recognition, unfolding and translocation into the proteasome core 17, 18 . PafA's biochemical activity remains to be discovered, but it appears that PafA has a role similar to that of Mpa in protein degradation 19 . Here we report the construction of mutants that allow conditional silencing of the proteasome a and b subunits, and we analyze the role of the Mtb proteasome in in vitro growth, in survival under protein-damaging conditions and during growth and persistence in mice.
RESULTS

Construction of conditional prcBA knockdown mutants
To generate mutants that allow conditional silencing of the Mtb proteasome, we integrated P myc1 tetO, a tetracycline-responsive mycobacterial promoter 5 , at the 5¢ end of prcBA, generating strain H37Rv P myc1 tetO:prcBA (Fig. 1a,b) . Placement of P myc1 tetO upstream of prcBA did not alter proteasome expression or in vitro growth of Mtb ( Supplementary Fig. 1 online) . Next, we transformed plasmids expressing wild-type Tet repressor (wtTetR) or reverse TetR (revTetR) 7 into H37Rv P myc1 tetO:prcBA. WtTetR represses P myc1 tetO in the absence of tetracyclines, whereas revTetR requires tetracyclines as cofactors for binding and silencing P myc1 tetO (ref. 20) . Addition of anhydrotetracycline thus induces expression of prcBA in H37Rv P myc1 tetO:prcBA-wtTetR (hereafter, PrcBA Tet-ON ) and silences expression of prcBA in H37Rv P myc1 tetO:prcBA-revTetR (PrcBA Tet-OFF ).
We analyzed the efficiencies and kinetics of prcBA silencing in PrcBA Tet-ON and PrcBA Tet-OFF by immunoblotting, mRNA quantification and proteasome activity assays (Fig. 1c-f) . As determined by immunoblotting, the abundance of the b subunit was reduced below the limit of detection after removal of anhydrotetracycline from PrcBA Tet-ON cultures or addition of anhydrotetracycline to PrcBA Tet-OFF cultures (Fig. 1c) . The amount of PrcBA transcripts was lowered by 93-95% after silencing in both mutants (Fig. 1d) . Anhydrotetracycline did not affect PrcB protein or prcBA transcript levels in the absence of wtTetR or revTetR (Fig. 1c,d) , showing that prcBA silencing was TetR dependent. To analyze proteasome activity, we measured the peptidolytic activity of Mtb lysates against succinyl-Leu-Leu-ValTyr-aminomethyl coumarin (Suc-LLVY-AMC), a fluorescent peptide substrate for the Mtb proteasome 10 . Four days after silencing was initiated, proteasome activity was reduced approximately 99% and 90% in the PrcBA Tet-OFF and PrcBA Tet-ON mutants, respectively (Fig. 1e) . After 7 d, proteasome activity was below the level of detection in both mutants. A similar difference between the Tet-ON and Tet-OFF strains in the kinetics of proteasome expression silencing was found in immunoblot analyses (Fig. 1f) . Together, these experiments show that PrcBA Tet-ON and PrcBA Tet-OFF allow rapid and efficient silencing of the mycobacterial proteasome in the absence (wtTetR, PrcBA Tet-ON ) or the presence (revTetR, PrcBA Tet-OFF ) of anhydrotetracycline, respectively. Silencing was slightly more efficient in the Tet-ON mutant but somewhat faster in the Tet-OFF mutant. These differences are probably due to the lower activity of revTetR compared to wtTetR in mycobacteria 7 and to residual anhydrotetracycline bound to Mtb after transfer of a Tet-ON strain into medium without anhydrotetracycline.
Impact of prcBA silencing on in vitro growth and stress resistance We next sought to determine the impact of prcBA silencing on in vitro growth and survival under nitrosative stress, because previous studies predicted that the Mtb proteasome is essential for optimal growth on agar plates and is required for defense against reactive nitrogen intermediates (RNI) 3, 15 . Proteasome depletion impaired growth of Mtb on agar plates and, to a small degree, in liquid culture (Fig. 2a) , and it also increased susceptibility to RNI (Fig. 2b) . After exposure of the cells to acidified nitrite for 3 d, silencing in the PrcBA Tet-ON mutant led to a 90% decrease in survival (P ¼ 0.005, Fig. 2b , left). PrcBA silencing in the Tet-OFF mutant did not significantly reduce the number of bacteria recovered after RNI stress (P ¼ 0.116, Fig. 2b , middle) suggesting that silencing in this mutant was not sufficient to cause decreased survival in this assay. Mutants in the proteasome-associated genes mpa and pafA were more resistant to H 2 O 2 than wild-type Mtb 15 was, and, similarly, depletion of the proteasome resulted in increased resistance to oxidative stress (P ¼ 0.002 for PrcBA Tet-ON and P ¼ 0.007 for PrcBA Tet-OFF , Fig. 2b ). The proteasome did not confer resistance or susceptibility to another physiological stress, acidic pH (data not shown). Anhydrotetracycline did not affect survival of the control strain (H37Rv P myc1 tetO:prcBA-no TetR) in the presence of acidified nitrite or H 2 O 2 (Fig. 2b, right) . In summary, these data support the proposed requirement for prcBA during optimal growth on agar plates and the proposed functional association of Mpa and PrcBA.
Impact of prcBA silencing on growth and persistence in mice We next used PrcBA Tet-ON and PrcBA Tet-OFF to determine the role of the proteasome during Mtb growth and persistence in mice. Tet-ON systems have been applied to infection models for pathogens such as Staphylococcus aureus and Yersinia pestis 21, 22 , but have not heretofore been used for analysis of Mtb mutant growth during mouse infections. Moreover, application of revTetR-dependent Tet-OFF systems to the in vivo analysis of a bacterial pathogen has not been reported. We first constructed an Mtb reporter strain containing a gfp gene controlled by P myc1 tetO and wtTetR (GFP Tet-ON ). GFP Tet-ON -infected mice fed doxycycline, a tetracycline derivative, had green fluorescent pulmonary Mtb, whereas no fluorescent bacteria were detected in mice that had not received doxycycline (Fig. 3) . This showed that the mycobacterial Tet-ON system allows for the control of Mtb gene expression during mouse infections. Next, we infected mice with the prcBA mutants and initiated proteasome silencing at day 1 (PrcBA Tet-ON ), day 7 (PrcBA Tet-OFF ) or day 21 (PrcBA Tet-OFF ) in different mice (Fig. 4) . In C57BL/6 mice, the onset of the adaptive immune response at around 3 weeks after infection results in control of Mtb replication, such that bacterial titers remain stable for many months 23 (Fig. 4d) . In contrast, lung bacterial counts measured 112 d after infection had 2.1-log (PrcBA Tet-ON ) and 2.7-log (PrcBA Tet-OFF ) reductions as a consequence of prcBA silencing (P ¼ 0.028 and P ¼ 0.0038; Fig. 4a,b) . Even when prcBA silencing was initiated only at the onset of the chronic phase of the infection (day 21, PrcBA Tet-OFF ), bacterial loads in lungs and spleens were 1.6-log and 1.3-log lower and P myc1 tetO-gfp-wtTetR (GFP Tet-ON , middle and bottom). Two weeks after infection, a group of mice received doxycycline (Doxy) for 6 d in their drinking water (bottom), whereas the control groups were kept without doxycycline (middle). The left column depicts lung tissues after rhodamineauramine staining to detect Mtb (60Â magnification). The middle and right columns show unstained fluorescent images obtained with a GFP filter at two magnifications (60Â and 150Â). (b) Bacterial titers in lungs of mice infected with H37Rv P myc1 tetO-gfp and H37Rv P myc1 tetO-gfp-wtTetR (GFP Tet-ON ) Mtb. CFU from mice treated with doxycycline starting 2 d and 14 d after infection are depicted. Control groups were kept without doxycycline. Data are means ± s.d. from four mice per group and time point. CFU counts from mice treated with doxycycline at day 12 were not significantly different from the other two data points, according to a Student's t-test.
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A less intense effect of prcBA silencing was observed during Mtb growth in the acute phase of infection. Colony-forming units (CFU) obtained at day 21 were 0.3-log lower after silencing of prcBA in the PrcBA Tet-ON mutant. This difference was larger (0.8-log) for the PrcBA Tet-OFF mutant, presumably owing to the faster kinetics of proteasome silencing in this strain (Fig. 4a,b) . The reduced growth of proteasome-depleted strains during the acute phase suggested that depletion of the Mtb proteasome during an infection of immunocompromised mice may extend their lifespans. Interferon-g-deficient (Ifng -/-) mice cannot control growth of Mtb 24 . We infected these mice with the PrcBA Tet-OFF mutant, allowed bacterial replication for 10 d and then induced prcBA silencing. This extended the mean survival time of the mice from 54 d to 81 d (P o 0.0001; Fig. 4f ). The Mtb proteasome is thus also essential for optimal in vivo growth, and its function goes beyond providing defense against the IFN-g-dependent elements of the host's immune response.
DISCUSSION
The genes encoding the Mtb core proteasome, prcB and prcA, were among the approximately 600 genes of the Mtb genome predicted to be essential or required for optimal growth in vitro 3 . This suggested that prcBA deletion mutants are not viable, and we therefore used conditional gene silencing to determine whether the prcBA genes are important for virulence of Mtb. Both Tet-ON and Tet-OFF systems allowed for efficient prcBA silencing and resulted in significant decreases in proteasome transcript and protein levels, as well as in proteasome activity. The silencing kinetics of the Tet-OFF system were slightly faster than those achieved with the Tet-ON system, even though the final proteasome abundance was lower after silencing with the Tet-ON system. Silencing of prcBA substantially impaired Mtb's growth on agar plates, which confirmed that the proteasome is required for optimal growth on this medium. However, prcBA silencing hardly affected growth in liquid culture, even though prcBA transcript levels were lowered more than tenfold and proteasome activity was reduced by approximately 99%. This suggests that prcBA may not be essential for growth in liquid medium.
We further validated the efficiency of prcBA silencing by showing that depletion of the proteasome rendered Mtb more susceptible to RNI and increased its resistance to H 2 O 2. These results are consistent with the phenotypes of mutants of the proteasome-associated genes mpa and pafA (ref. 15) . Increased resistance to organic peroxide has also been reported for S. coelicolor proteasome mutants and was accompanied by increased levels of haloperoxidase 25 . The mechanisms by which the core proteasome protects Mtb against nitrosative damage may include removal of nitrosylated proteins, as shown in mammalian cells 26 . However, our previous data suggest that the role of the Mtb proteasome extends beyond defense against RNI. Infection of Ifng -/-mice with proteasome-depleted Mtb extended their life span compared to that of mice infected with proteasome-expressing Mtb. Additionally, an Mtb mpa mutant was not fully virulent in mice lacking inducible nitric oxide synthase 15 .
Silencing of prcBA transcription during mouse infections showed that the Mtb proteasome is not only required for optimal in vivo growth, but is also essential during the chronic phase of the infection, when the pathogen replicates slowly or not at all 27 . The eukaryotic proteasome participates in protein turnover, transcription and DNA repair 28 . It is unclear by which of these processes Mtb's proteasome allows the pathogen to persist in its host. The phenotypes observed in mutants of the proteasomal ATPase Mpa suggested that the core proteasome is required for growth of Mtb in mice 15, 16 but did not predict a role for the proteasome during the chronic phase of infection.
Analyses of prcBA provided proof of principle that transcriptional silencing permits inactivation of Mtb genes during different stages of infection in mice. Reporter gene studies and experiments with other mutants showed that TetR-mediated gene silencing is dependent on anhydrotetracycline dose 5, 7 . This suggests that gene silencing can determine to which extent a gene has to be inactivated before mycobacterial growth or survival is impaired. Both of these features, conditionality and dose-responsiveness, distinguish gene silencing from deletion and transposon mutagenesis and are not only important for functional analyses but also relevant to the development of new drugs to treat tuberculosis. Chemotherapy must be administered during different phases of an infection, including the chronic phase, and is probably most effective if it inhibits processes that are essential during all stages of an infection 29 . Conditional gene silencing facilitates the genetic identification of such processes. In addition, the development of drugs that completely inactivate a target is difficult. Experiments that use gene silencing to partially inactivate a gene might therefore help to focus drug development on targets whose inactivation is effective, even when incomplete.
In addition to the opportunities that gene silencing offers, the approach also has its challenges. The true impact of target inactivation might be masked by compensatory mutations, epigenetic changes or the residual transcription that occurs despite silencing. Careful analysis of bacterial populations after gene silencing, for example, with respect to the frequency of suppressor mutations and the residual expression of the target protein is required to interpret experiments in which gene silencing does not lead to a phenotypic effect. In addition, for some genes it might be necessary to tailor the activity of the regulated promoter to the target gene's native expression level in order to achieve proper promoter replacement. This could be accomplished with a library of well-regulated promoters that differ in their induced activities. The continued improvement of gene silencing tools for mycobacteria should therefore further facilitate the validation of targets for the development of new drugs for tuberculosis.
METHODS
Strains, media and culture conditions. Wild-type Mtb (H37Rv) was a gift (see Acknowledgments). We grew mycobacteria in Middlebrook 7H9 medium (Difco) with 0.2% glycerol and 0.05% Tween 80 supplemented with 0.5% BSA, 0.2% dextrose and 0.085% sodium chloride (ADN). We selected recombinant mycobacteria on 50 mg/ml hygromycin B and 15 mg/ml kanamycin as required. We used anhydrotetracycline at 100 ng/ml and replenished it every 4 d in liquid culture.
Construction of prcBA Tet-ON and prcBA Tet-OFF mutants. We integrated P myc1 tetO at the 5¢ end of prcBA on the Mtb chromosome by homologous recombination after transduction with temperature-sensitive mycobacteriophage 30 . To achieve this, we amplified the 768 base pairs (bp) that are 5¢ of the start codon of prcB and the first 675 bp of prcB by PCR from H37Rv genomic DNA. We cloned the DNA fragments to flank the hygromycin resistance gene in pJSC284, a derivative of pYUB854 containing a lambda cos site, and a unique PacI site 30 . We cloned P myc1 tetO upstream of the start codon of prcB and a transcriptional terminator downstream of the hygromycin resistance gene. We ligated the plasmid with temperature-sensitive phage phAE87 (ref. 30 ) and used the resulting phage to infect Mtb. We selected hygromycin-resistant transductants on 7H11 agar plates with 50 mg/ml hygromycin for 3 weeks and analyzed them by Southern blotting. We transformed recombinants by electroporation with plasmids encoding wtTetR, revTetR or no TetR and selected transformants on hygromycin and kanamycin in the presence (wtTetR) or absence (revTetR, no TetR) of anhydrotetracycline.
Analysis of prcBA mRNA by quantitative real time PCR and PrcB protein by immunoblotting. We grew PrcBA Tet-ON and PrcBA Tet-OFF mutants to an optical density (OD) 580nm of 0.8-1.0 in the presence or absence of anhydrotetracycline. We prepared RNA from 10-ml cultures and synthesized cDNA using random hexamers as primers. We performed RT-PCR using specific TaqMan probes for prcA (encodes proteasome a subunit), sigA (encodes sigma factor SigA), rrs (encodes 16S rRNA) and rpoB (encodes RNA polymerase b subunit) and included a control reaction lacking reverse transcriptase for every RNA sample. For immunoblots, we prepared cell lysates by bead-beating in PBS containing Complete Mini protease inhibitor cocktail (Roche). We subjected 15 mg of the cell lysates to SDS-PAGE followed by transfer to a nitrocellulose membrane. We probed blots with PrcB-specific and dihydrolipoamide acyltransferase (DlaT)-specific rabbit sera and developed them with Immobilon Western Chemiluminescent HRP substrate (Millipore).
Proteasome activity assay. We grew bacteria to OD 580nm 1.0 in the presence or absence of anhydrotetracycline and lysed cell pellets from 10-ml cultures in PBS containing Complete Mini protease inhibitor cocktail with a bead beater. We sterilized clarified lysates by passing them through a 0.2-mm filter. We determined proteasome activity as described elsewhere 10 . Briefly, we incubated 50 mg of lysate with 100 mM Suc-LLVY-AMC (Boston Biochem) in 20 mM HEPES, 0.5 mM EDTA buffer and monitored fluorescence at excitation of 370 nm and emission of 430 nm at 37 1C over 60 min.
In vitro stress susceptibility assays. We grew Mtb cultures for 7 d to log phase (OD 580nm 0.6) in the presence or absence of 100 ng/ml anhydrotetracycline. We prepared single-cell suspensions of cultures by centrifugation at 123 Â g for 10 min and subsequently diluted them to OD 580nm 0.01. To test susceptibility to RNI, we diluted and incubated cultures at pH 5.5 with or without 3 mM NaNO 2 for 3 d at 37 1C. To test susceptibility to H 2 O 2 , we incubated cultures at pH 6.8 with or without 5 mM H 2 O 2 for 4 h at 37 1C. We maintained cultures containing anhydrotetracycline in medium with anhydrotetracycline during the course of the experiment. To determine viability, we plated serial dilutions of cultures on 7H11 plates (Difco) with anhydrotetracycline for H37Rv PrcBA Tet-ON and on plates without anhydrotetracycline for all other strains.
Animal infections. We grew the PrcBA tet-ON mutant in the presence of anhydrotetracycline and the PrcBA tet-OFF mutant and H37Rv-revTetR in the absence of anhydrotetracycline to early log phase. We used single cell suspensions to infect female C57BL/6 mice and IFNg -/-mice on a C57BL/6 genetic background (Jackson Laboratory) via aerosol using a Middlebrook Inhalation Exposure System (Glas-Col). Groups of infected mice received 1 mg/ml doxycycline in drinking water containing 5% sucrose. We kept doxycyclinecontaining water in light-protected bottles and changed the bottles twice a week. We determined bacterial burden in lungs and spleen by plating for CFU at the indicated times. We used the log-rank test to determine the statistical significance of survival differences observed in PrcBA tet-OFF mutant-infected IFNg À/À mice (GraphPad Prism 4.0). Mouse procedures were reviewed and approved by the Institutional Animal Care and Use Committee of Weill Cornell Medical College.
Fluorescence microscopy of Mtb in mouse lungs. We infected C57BL/6 mice by aerosol with 100 CFU of Mtb transformed with P myc1 tetO-gfp or P myc1 tetOgfp-wtTetR. Two weeks after infection, one group of mice received 1 mg/ml doxycycline in drinking water containing 5% sucrose, whereas the control groups were kept without doxycycline. Six days later, we killed the mice, fixed lung tissues for 24-36 h in 10% formalin and analyzed frozen 10-mm-thick sections of lung tissues microscopically. We acquired images with a Leica DMIRB wide-field microscope with a 40Â 1.25 and a 100Â 1.25 numerical aperture objective and a 1.5Â magnification changer.
Note: Supplementary information is available on the Nature Medicine website.
